Title

Updates in Pharmacotherapy for Melanoma

Document Type

Article

Publication Date

6-2018

Abstract

The incidence of melanoma continues to increase exponentially. It was estimated that, in 2016, 76,380 people in the United States would be diagnosed with melanoma and about 10,130 would die of this disease. Survival rates have started to improve because of new and emerging systemic therapies, including immunotherapy and targeted therapy. The National Comprehensive Cancer Network has updated its guidelines on the use of immunotherapy and targeted therapy in melanoma. Pharmacists can help the clinician select the most appropriate therapy and can actively conduct patient education.

Publication Title

U.S. Pharmacist

Volume

43

Issue

6

First Page

HS2

Last Page

HS8

Comments

This article was published in U.S. Pharmacist, Volume 43, Issue 6, Pages HS2-HS8.

The published version is available at https://www.uspharmacist.com/article/updates-in-pharmacotherapy-for-melanoma.

Copyright © 2018.

This document is currently not available here.

COinS